Pulmonary Disease in the Immunocompromised Host, An Issue of Clinics in Chest Medicine

In this issue of <i>Clinics in Chest Medicine</i>, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of <b>Pulmonary Disease in the Immunocompromised Host</b>. Top experts discuss imaging the immunocompromised lung; laboratory molecular testing in immunocompromised host pneumonia; vaccines and other preventative strategies for immunocompromised pneumonia; adjunctive/host-directed therapies in immunocompromised host pneumonia; sequelae of immunocompromised host pneumonia; and more.<ul><li>Contains <b>16 relevant, practice-oriented topics</b> including COVID-19 and emerging lung infections in the immunocompromised patient; pulmonary immunocompromise in stem cell transplantation and cellular therapy; pulmonary immunocompromise in solid organ transplantation; pulmonary immunocompromise in chronic and high dose steroid therapy; and more</li><li>Provides in-depth <b>clinical reviews on pulmonary disease in the immunocompromised host</b>, offering actionable insights for clinical practice</li><li>Presents the <b>latest information on this timely, focused topic</b> under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews</li></ul>